Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 46 results.
User Information
Export Records
  1. 1.   Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
  2. Sui, Yongjun; Lewis, George K.; Wang, Yichuan; Berckmueller, Kurt; Frey, Blake; Dzutsev, Amiran; Vargas-Inchaustegui, Diego; Mohanram, Venkatramanan; Musich, Thomas; Shen, Xiaoying; DeVico, Anthony; Fouts, Timothy; Venzon, David; Kirk, James; Waters, Robert C.; Talton, James; Klinman, Dennis; Clements, John; Tomaras, Georgia D.; Franchini, Genoveffa; Robert-Guroff, Marjorie; Trinchieri, Giorgio; Gallo, Robert C.; Berzofsky, Jay A.
  3. The Journal of clinical investigation. 2019, Mar 1; 129(3): 1314-1328.
  1. 2.   Gp96(SIV)Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa
  2. Strbo, N.; Vaccari, M.; Pahwa, S.; Kolber, M. A.; Fisher, E.; Gonzalez, L.; Doster, M. N.; Hryniewicz, A.; Felber, B. K.; Pavlakis, G. N.; Franchini, G.; Podack, E. R.
  3. Vaccine. 2011, Mar; 29(14): 2619-2625.
  1. 3.   HIV-1 infected monozygotic twins: a tale of two outcomes
  2. Tazi, L. T. L.; Imamichi, H.; Hirschfeld, S.; Metcalf, J. A.; Orsega, S.; Perez-Losada, M.; Posada, D.; Lane, H. C.; Cr, all
  3. Bmc Evolutionary Biology. 2011, Mar; 11: 9.
  1. 4.   Envelope-Modified Single-Cycle Simian Immunodeficiency Virus Selectively Enhances Antibody Responses and Partially Protects against Repeated, Low-Dose Vaginal Challenge
  2. Alpert, M. D.; Rahmberg, A. R.; Neidermyer, W.; Ng, S. K.; Carville, A.; Camp, J. V.; Wilson, R. L.; Piatak, M.; Mansfield, K. G.; Li, W. J.; Miller, C. J.; Lifson, J. D.; Kozlowski, P. A.; Evans, D. T.
  3. Journal of Virology. 2010, Oct; 84(20): 10748-10764.
  1. 5.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 6.   In situ detection of Gag-specific CD8(+) cells in the GI tract of SIV infected Rhesus macaques
  2. Tjernlund, A.; Zhu, J.; Laing, K.; Diem, K.; McDonald, D.; Vazquez, J.; Cao, J. H.; Ohlen, C.; McElrath, M. J.; Picker, L. J.; Corey, L.
  3. Retrovirology. 2010, Feb; 7: 14.
  1. 7.   Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503
  2. Thammavongsa, V.; Schaefer, M.; Filzen, T.; Collins, K. L.; Carrington, M.; Bangia, N.; Raghavan, M.
  3. Immunogenetics. 2009, Dec; 61(11-12): 703-716.
  1. 8.   Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals
  2. Kearney, M.; Maldarelli, F.; Shao, W.; Margolick, J. B.; Daar, E. S.; Mellors, J. W.; Rao, V.; Coffin, J. M.; Palmer, S.
  3. Journal of Virology. 2009 83(6): 2715-2727.
  1. 9.   The Mamu B*17-restricted SIV NefIW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness
  2. Minang, J. T.; Trivett, M. T.; Coren, L. V.; Barsov, E. V.; Piatak, M.; Chertov, O.; Chertova, E.; Ott, D. E.; Ohlen, C.
  3. Virology. 2008 375(1): 307-314.
  1. 10.   Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  2. Earl, P. L.; Americo, J. L.; Wyatt, L. S.; Eller, L. A.; Montefiori, D. C.; Byrum, R.; Piatak, M.; Lifson, J. D.; Amara, R. R.; Robinson, H. L.; Huggins, J. W.; Moss, B.
  3. Virology. 2007, Sep; 366(1): 84-97.
  1. 11.   Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity
  2. Shirota, H.; Petrenko, L.; Hong, C.; Klinman, D. M.
  3. Journal of Immunology. 2007, Jul; 179(1): 329-336.
  1. 12.   Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations
  2. Spierings, E.; Hendriks, M.; Absi, L.; Canossi, A.; Chhaya, S.; Crowley, J.; Dolstra, H.; Eliaou, J. F.; Ellis, T.; Enczmann, J.; Fasano, M. E.; Gervais, T.; Gorodezky, C.; Kircher, B.; Laurin, D.; Leffell, M. S.; Loiseau, P.; Malkki, M.; Markiewicz, M.; Martinetti, M.; Maruya, E.; Mehra, N.; Oguz, F.; Oudshoorn, M.; Pereira, N.; Rani, R.; Sergeant, R.; Thomson, J.; Tran, T. H.; Turpeinen, H.; Yang, K. L.; Zunec, R.; Carrington, M.; de Knijff, P.; Goulmy, E.
  3. Plos Genetics. 2007, Jun; 3(6): 1108-1119.
  1. 13.   Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239
  2. Boyer, J. D.; Maciag, P. C.; Parkinson, R.; Wu, L.; Lewis, M. G.; Weiner, D. B.; Paterson, Y.
  3. Vaccine. 2006, May; 24(21): 4498-4502.
  1. 14.   Impact of vaccine-induced mucosal high-avidity CD8(+)CTLs in delay of AIDS viral dissemination from mucosa
  2. Belyakov, I. M.; Kuznetsov, V. A.; Kelsall, B.; Klinman, D.; Moniuszko, M.; Lemon, M.; Markham, P. D.; Pal, R.; Clements, J. D.; Lewis, M. G.; Strober, W.; Franchini, G. A.; Berzofsky, J. A.
  3. Blood. 2006, Apr; 107(8): 3258-3264.
  1. 15.   Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes
  2. Hel, Z.; Tsai, W. P.; Tryniszewska, E.; Nacsa, J.; Markham, P. D.; Lewis, M. G.; Pavlakis, G. N.; Felber, B. K.; Tartaglia, J.; Franchini, G.
  3. Journal of Immunology. 2006, Jan; 176(1): 85-96.
  1. 16.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 17.   High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B
  2. Quinto, I.; Puca, A.; Greenhouse, J.; Silvera, P.; Yalley-Ogunro, J.; Lewis, M. G.; Palmieri, C.; Trimboli, F.; Byrum, R.; Adelsberger, J.; Venzon, D.; Chen, X. N.; Scala, G.
  3. Journal of Biological Chemistry. 2004 279(3): 1720-1728.
  1. 18.   Reversion of CTL escape-variant immunodeficiency viruses in vivo
  2. Friedrich, T. C.; Dodds, E. J.; Yant, L. J.; Vojnov, L.; Rudersdorf, R.; Cullen, C.; Evans, D. T.; Desrosiers, R. C.; Mothe, B. R.; Sidney, J.; Sette, A.; Kunstman, K.; Wolinsky, S.; Piatak, M.; Lifson, J.; Hughes, A. L.; Wilson, N.; O'Connor, D. H.; Watkins, D. I.
  3. Nature Medicine. 2004 10(3): 275-281.
  1. 19.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 20.   Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model
  2. Nelson, E. L.; Prieto, D.; Alexander, T. G.; Pushko, P.; Lofts, L. A.; Rayner, J. O.; Kamrud, K. I.; Fralish, B.; Smith, J. F.
  3. Breast Cancer Research and Treatment. 2003 82(3): 169-183.
  1. 21.   Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques
  2. Calarota, S. A.; Otero, M.; Hermanstayne, K.; Lewis, M.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Boyer, J. D.; Weiner, D. B.
  3. Journal of Immunological Methods. 2003 279(1-2): 55-67.
  1. 22.   Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection
  2. Liu, C. L.; Carrington, M.; Kaslow, R. A.; Gao, X. J.; Rinaldo, C. R.; Jacobson, L. P.; Margolick, J. B.; Phair, J.; O'Brien, S. J.; Detels, R.
  3. Journal of Infectious Diseases. 2003 187(9): 1404-1410.
  1. 23.   Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
  2. Willey, R. L.; Byrum, R.; Piatak, M.; Kim, Y. B.; Cho, M. W.; Rossio, J. L.; Bess, J.; Igarashi, T.; Endo, Y.; Arthur, L. O.; Lifson, J. D.; Martin, M. A.
  3. Journal of Virology. 2003 77(2): 1163-1174.
  1. 24.   The differential ability of HLA b*5701(+) long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences
  2. Migueles, S. A.; Laborico, A. C.; Imamichi, H.; Shupert, W. L.; Royce, C.; McLaughlin, M.; Ehler, L.; Metcalf, J.; Liu, S. Y.; Hallahan, C. W.; Connors, M.
  3. Journal of Virology. 2003 77(12): 6889-6898.
  1. 25.   Production and purification of refolded recombinant human IL-7 from inclusion bodies
  2. Ouellette, T.; Destrau, S.; Zhu, J. W.; Roach, J. M.; Coffman, J. D.; Hecht, T.; Lynch, J. E.; Giardina, S. L.
  3. Protein Expression and Purification. 2003 30(2): 156-166.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel